Medlab is an Australian biotechnology company (ASX:MDC) focused on the delivery of medicinal solutions and hope for patients with unmet needs.
Our dedicated team is continually developing our proprietary active ingredient delivery technology, NanoCelle®, creating more opportunities to safely and efficiently bring transformative medicines to patients.
We offer agile innovative research with expertise in both large and small molecule delivery – through the entire supply chain process, from concept to the manufactured end product.
Improving Quality of Life
Medlab strives to find new ways to address the biggest challenges of our time, including the growing burden of chronic conditions, suboptimal pain management as well as enhancing drug delivery options – with innovative nanotechnology, NanoCelle®.
With a diverse portfolio ranging across therapeutic areas such as mental health, oncology pain management and over-the-counter nutraceuticals – we specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life.
We aim to improve people’s lives by striving to maximise the value of every medicine we create and getting them to the people who need it most, as quickly and efficiently as possible.
At Medlab, our four core values reflect and shape the company’s personality and the relationships we develop with our people and our clients – they are at the heart of how we work.